EP 3854418 A4 20220727 - TREATMENT OF HER3 MUTANT CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE
Title (en)
TREATMENT OF HER3 MUTANT CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE
Title (de)
BEHANDLUNG VON HER3 -MUTANTEM KREBS DURCH VERABREICHUNG VON ANTI-HER3-ANTIKÖRPER-ARZNEIMITTEL-KONJUGAT
Title (fr)
TRAITEMENT D'UN CANCER À HER3 MUTANT PAR L'ADMINISTRATION D'UN CONJUGUÉ ANTICORPS ANTI-HER3-MÉDICAMENT
Publication
Application
Priority
- JP 2018175510 A 20180920
- JP 2019036668 W 20190919
Abstract (en)
[origin: EP3854418A1] A therapeutic agent for HER3-mutated cancer containing an anti-HER3 antibody-drug conjugate as an active ingredient and/or a method of treatment for cancer, the method including administering an anti-HER3 antibody-drug conjugate to a subject determined to have HER3-mutated cancer.
IPC 8 full level
A61K 31/437 (2006.01); A61K 39/395 (2006.01); A61K 47/65 (2017.01); A61K 47/68 (2017.01); A61P 1/00 (2006.01); A61P 11/00 (2006.01); A61P 15/00 (2006.01); A61P 17/00 (2006.01); A61P 25/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR US)
A61K 31/437 (2013.01 - KR); A61K 47/6803 (2017.07 - EP US); A61K 47/6851 (2017.07 - KR); A61K 47/6855 (2017.07 - EP US); A61P 1/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP KR); C07K 16/32 (2013.01 - EP KR US)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 2020059772A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3854418 A1 20210728; EP 3854418 A4 20220727; BR 112021005246 A2 20210615; CA 3113207 A1 20200326; CN 112912109 A 20210604; JP WO2020059772 A1 20210830; KR 20210062005 A 20210528; TW 202024133 A 20200701; US 2022072144 A1 20220310; WO 2020059772 A1 20200326
DOCDB simple family (application)
EP 19863647 A 20190919; BR 112021005246 A 20190919; CA 3113207 A 20190919; CN 201980061665 A 20190919; JP 2019036668 W 20190919; JP 2020548575 A 20190919; KR 20217007188 A 20190919; TW 108133829 A 20190919; US 201917276394 A 20190919